Skip to content
naulon
Not checkedNot checked for notices yet.

Thymomas: five-year outcomes of open surgery and a single centre experience

Aram Baram

Journal of International Medical Research · 2019

doi:10.1177/0300060519868339 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objective To present and discuss the clinical course, management, recurrence and survival of patients with thymoma at a single centre. Methods This prospective observational study included patients with confirmed thymoma who were diagnosed and managed over a 10-year period. Results The study included 89 patients (mean ± SD age, 48.53 ± 11.60 years). There were 46 (51.7%) males and 43 (48.3%) females. The mean duration of follow-up was 60 months (range, 2 months to 8 years). Stage II was the most common stage (37 [41.6%]), followed by stage I with 30 (33.7%) patients, stage IIIA with 11 (12.4%) patients, stage IVA with six (6.7%) patients and stage IIIB with five (5.6%) patients. Overall (actuarial) 5-year survival was achieved by 84 of 89 patients (94.4%). Stage-specific survival was as follows: 100% in stage I (30 of 30 patients), 100% in stage II (37 of 37 patients), 54.5% in stage IIIA (six of 11 patients), 80.0% in stage IIIB (four of five patients) and 50.0% in stage IVA (three of six patients). Conclusion Complete surgical resection is the main modality used for the definitive diagnosis, staging and surgical cure of thymoma.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.